Tapewire

Nasdaq · USD

LABT

Lakewood-Amedex Biotherapeutics Inc.

Export transactions ↓
Tapewire entity
8154
SEC CIK
0002079272
Parsed reports
6

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 24, 2026 Filed May 6, 2026 22:20 UTC GrantWarrant to acquire Common Stock · Derivative 33,784 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001193125-26-209581 · ownership.xml · derivative · entry 1

Tucker Joseph Edward · CIK 0001883914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,784

Underlying: Common Stock · 33,784 shares

Expires 2036-04-23

F1 · derivative.exercise_date: The warrants vest in four equal tranches of 8,446 warrants each on October 24, 2026, April 24, 2027, October 24, 2027, and April 24, 2028.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.